Butler Hospital: Opioid-Related Disorders trials

The registry lists 12 Opioid-Related Disorders studies with Butler Hospital as lead sponsor. 1 are open to participants now and 4 have results posted.

Phase 3 5No phase 7(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• tDCS to Decrease Opioid Relapse (UH3)RecruitingNCT06432465Not applicable
• tDCS to Decrease Opioid Relapse (UG3)CompletedNCT03842137Not applicableResults posted
• Neuroimaging Predictors of Relapse During Treatment for Opiate DependenceCompletedNCT02696096Phase 3Results posted
• SSRI and BuprenorphineCompletedNCT00475878Phase 3Results posted
• Insomnia and Drug Relapse RiskCompletedNCT00253890Phase 3Results posted
• Changing Opioid Users' Negative Attitudes Toward Medication Assisted TreatmentWithdrawnNCT03151655Not applicable
• Transforming Recovery Through Exercise and CommunityCompletedNCT03065049Not applicable
• Study of Yoga vs. Health Education for Chronic Pain in Persons Receiving Opioid Agonist TherapyCompletedNCT03022890Not applicable
• Behavioral Consultation for HIV+ Older Adults Prescribed Opioids for Chronic PainCompletedNCT02272829Not applicable
• Distress Tolerance and BuprenorphineCompletedNCT01556087Phase 3
• Linking Hospitalized Injection Drug Users to BuprenorphineCompletedNCT00987961Phase 3
• Interactive Voice Response (IVR) for Methadone PatientsCompletedNCT00237406